Send the following on WhatsApp
Continue to ChatI liked this article on M3 India: A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: The ZAP trial. Have a read: https://www.m3india.in/contents/journal/a-phase-ii-study-evaluating-the-efficacy-of?utm_campaign=unset&utm_medium=share&utm_source=ref_wa